Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash from Operations: 2009-2024

Historic Cash from Operations for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $2.5 billion.

  • Fresenius Medical Care AG's Cash from Operations fell 19.84% to $866.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 13.55%. This contributed to the annual value of $2.5 billion for FY2024, which is 10.33% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Cash from Operations of $2.5 billion as of FY2024, which was down 10.33% from $2.8 billion recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Cash from Operations registered a high of $4.8 billion during FY2020, and its lowest value of $2.3 billion during FY2022.
  • Over the past 3 years, Fresenius Medical Care AG's median Cash from Operations value was $2.5 billion (recorded in 2024), while the average stood at $2.6 billion.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Cash from Operations skyrocketed by 68.13% in 2020, and later crashed by 39.05% in 2021.
  • Fresenius Medical Care AG's Cash from Operations (MRY) stood at $4.8 billion in 2020, then tumbled by 39.05% to $2.9 billion in 2021, then decreased by 22.46% to $2.3 billion in 2022, then rose by 24.48% to $2.8 billion in 2023, then fell by 10.33% to $2.5 billion in 2024.
  • Its Cash from Operations stands at $2.5 billion for FY2024, versus $2.8 billion for FY2023 and $2.3 billion for FY2022.